| Academic detailing interventions for opioid-related outcomes: a scoping review V Kulbokas, KA Hanson, MH Smart, MR Mandava, TA Lee, AS Pickard Drugs in Context 10, 2021 | 11 | 2021 |
| Real-world treatment patterns and clinical outcomes associated with palbociclib combination therapy: a multinational, pooled analysis from the Ibrance real world insights study K Mycock, KA Hanson, G Taylor-Stokes, G Milligan, C Atkinson, D Mitra, ... Clinical Therapeutics 44 (12), 1588-1601, 2022 | 7 | 2022 |
| Pharmacists and naloxone: barriers to dispensing and effectiveness of an educational outreach program KA Hanson, MH Smart, MR Mandava, E Carkovic, M Aslamy, TA Lee, ... Journal of the American Pharmacists Association 63 (2), 608-613. e3, 2023 | 5 | 2023 |
| Place in therapy of cyclin-dependent kinase 4/6 inhibitors in breast cancer: A targeted literature review M Zhao, KA Hanson, Y Zhang, A Zhou, AS Cha-Silva Targeted Oncology 18 (3), 327-358, 2023 | 3 | 2023 |
| The Clone-Censor-Weight Method in Pharmacoepidemiologic Research: Foundations and Methodological Implementation CE Gaber, KA Hanson, S Kim, JL Lund, TA Lee, EJ Murray Current Epidemiology Reports, 1-11, 2024 | 1 | 2024 |
| Optimizing large real-world data analysis with parquet files in R: A step-by-step tutorial A Abdelaziz, K Hanson, C Gaber, T Lee Pharmacoepidemiology and Drug Safety, 2023 | 1 | 2023 |
| Real-world comparative effectiveness and cardiovascular safety of enzalutamide versus abiraterone amongst older men diagnosed with metastatic castration-resistant prostate cancer. C Gaber, E Okpara, A Abdelaziz, J Sarker, K Hanson, L Hassan, FJ Lin, ... Journal of Clinical Oncology 42 (16_suppl), 5053-5053, 2024 | | 2024 |
| Real-World Assessment of Disease Characteristics and Clinical Outcomes in Alopecia Areata in a Global Noninterventional Observational Cohort (ADAAGIO) K Davis, A Messenger, S Vano Galvan, T H, L Napatalung, K Hanson, ... SKIN The Journal of Cutaneous Medicine 8 (2), s395, 2024 | | 2024 |
| OFF episode quality of life impact scale (OFFELIA): A new measure of quality of life for off episodes in Parkinson's disease M Kuharic, V Kulbokas, K Hanson, ... Parkinsonism & Related Disorders, 2024 | | 2024 |
| EE280 Real-World Healthcare Resource Utilization of Patients with Metastatic Breast Cancer: A Retrospective Cohort Analysis K Hanson, A Cha-Silva, M Hull, M DeKoven, VR Anupindi, R Doshi, ... Value in Health 26 (6), S110, 2023 | | 2023 |
| PCR71 Off Episode Quality of Life Impact Scale (OFFELIA): Overview of the Development of a Quality of Life and Functional Impact Measure of Off Episodes in Parkinson's Disease M Kuharic, K Shah, K Hanson, J Nazari, V Kulbokas, A Nguyen, T Hensle, ... Value in Health 25 (12), S403-S404, 2022 | | 2022 |
| Work productivity among patients with metastatic breast cancer in the United States S Durgapal, K Hanson, SK Kurosky, S Kautz, S Sison, C Cool Expert Review of Pharmacoeconomics & Outcomes Research 22 (7), 1137-1145, 2022 | | 2022 |
| Challenges to Naloxone Dispensing By Community Pharmacists: Results from an Educational Outreach Initiative K Hanson, AS Pickard, M Smart, M Mandava, E Carkovic, M Aslamy, ... 2022 Annual Research Meeting, 2022 | | 2022 |
| POSB400 Real World Treatment Patterns and Clinical Outcomes Associated with Palbociclib Combination Therapy across Europe, North and South America, and ASIA: A Pooled Analysis … K Mycock, K Hanson, G Taylor-Stokes, G Milligan, C Atkinson, D Mitra, ... Value in Health 25 (1), S259, 2022 | | 2022 |
| POSA396 Work Productivity in Patients with Metastatic Breast Cancer: A Retrospective Analysis of Claims Data in the US S Durgapal, S Kautz, K Ching, S Sison, K Hanson, S Kurosky, C Cool Value in Health 25 (1), S250, 2022 | | 2022 |
| Abstract PO-097: Racial/ethnic disparities in the survival of HR+/HER2-early breast cancer using the CPS+ EG scoring system KA Hanson, KF Hoskins, NY Ko, GS Calip Cancer Epidemiology, Biomarkers & Prevention 31 (1_Supplement), PO-097-PO-097, 2022 | | 2022 |
| Multi-gene prognostic assays and age-related differences in prediction of pathologic complete response to neoadjuvant chemotherapy and survival in breast cancer. K Hanson, K Hoskins, NY Ko, GS Calip Journal of Clinical Oncology 39 (15_suppl), 591-591, 2021 | | 2021 |
Todd A. LeeUniversity of Illinois ChicagoVerified email at uic.edu
